Blarcamesine, Developed by Anavex Life Sciences, Shows Promise in Phase 2 Extension Study
Anavex Life Sciences, a biopharmaceutical company at the forefront of developing innovative therapies for neurological disorders, has announced positive findings from the 48-week,…